Clinical Trial Update: Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating cryoablation in combination with lenvatinib and QL1706 for advanced intrahepatic cholang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• LENVIMA (lenvatinib)
• QL1706 (Iparomlimab/Tuvonralimab) (iparomlimab / tuvonralimab)

Snippet

Sponsor: Fudan University | Conditions: Intrahepatic Cholangiocarcinoma (Icc) | Phase 2 | Status: RECRUITING